Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes.

Xichao MoXuwen XuZuning RenJunjie Guan Jie Peng

Published in: Infectious diseases (London, England) (2020)

Our study demonstrated that HBV co-infection could increase the incidence of ATB-DILI and the risk of poor outcomes as identified by three predictors in TBM patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
hepatitis b virus
peritoneal dialysis
risk factors
type diabetes
electronic health record